IP Library Granted Patent US 8,865,230
Granted Patent B2
US 8,865,230 · App. 13/592,127 · Granted Oct 21, 2014

Compositions and methods for treating parasitic infections

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,230
App. No.
13/592,127
Granted
Oct 21, 2014
Kind
B2
Abstract

Compositions for treating parasitic infections and methods of using the compositions to treat subjects with parasitic infections are provided. Methods of selecting compositions for use in treating parasitic infections are further provided.

Claims (7)

1. A method of treating a parasitic infection in a mammal or bird in need thereof, comprising administering to the mammal or bird a composition which comprises between 9.92% and 37.2% isolated para-cymene, between 6.36% and 9.8% isolated linalool, between 3.2% and 4.07% isolated alpha-pinene and between 13.5% and 46.2% isolated thymol wherein the composition is encapsulated or microencapsulated with an outer shell material.

2. The method of claim 1 , wherein the parasitic infection is by a parasite selected from the group consisting of a protozoan parasite, and a helminthic parasite.

3. The method of claim 2 , wherein the parasite is selected from the group consisting of Entamoeba hystolytica, Giardia lamblia, Cryptosporidium muris, Trypanosomatida gambiense, Trypanosomatida rhodesiense, Trypanosomatida crusi, Leishmania mexicana, Leishmania braziliensis, Leishmania tropica, Leishmania donovani, Toxoplasma gondii, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, Plasmodium falciparum, Trichomonas vaginalis, Histomonas meleagridis, Trichuris trichiura, Ascaris lumbricoides, Enterobius vermicularis, Ancylostoma duodenale, Necator americanus, Strongyloides stercoralis, Wuchereria bancrofti, Dracunculus medinensis, Schistosoma mansoni, Schistosoma haematobium, Schistosoma japonicum, Fasciola hepatica, Fasciola gigantica, Heterophyes heterophyes, Paragonimus westermani, Taenia solium, Taenia saginata, Hymenolepis nana , and Echinococcus granulosus.

4. The method of claim 1 , wherein the mammal is selected from the group consisting of a human, a ruminant, an ungulate, a swine, poultry, a horse, and a carnivore.

5. The method of claim 1 , wherein the composition comprises a carrier.

6. The method of claim 5 , wherein the carrier is a food product.

7. The method of claim 1 , wherein the composition comprises about 28.39% by weight isolated para-cymene, about 6.6% by weight isolated linalool, about 3.8% by weight isolated alpha-pinene, and about 37.2% by weight isolated thymol.

Assignments (2)
SECURITY INTEREST Recorded Mar 24, 2026
From: AMVAC CHEMICAL CORPORATION; TYRATECH, INC.
To: BMO BANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075188/0405 →
SECURITY INTEREST Recorded Mar 13, 2026
From: TYRATECH, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 074076/0454 →